Teriflunomide in the treatment of multiple sclerosis: current evidence and future prospects.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2014, v. 7, n. 5, p. 239, doi. 10.1177/1756285614546855
- By:
- Publication type:
- Article
Works matching IS 17562856 AND DT 2014 AND VI 7 AND IP 5
Results: 4
1
2
Fumarate treatment in progressive forms of multiple sclerosis: first results of a single-center observational study.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2014, v. 7, n. 5, p. 232, doi. 10.1177/1756285614544466
- By:
- Publication type:
- Article
3
Isoniazid in autoimmunity: a trigger for multiple sclerosis?
- Published in:
- Therapeutic Advances in Neurological Disorders, 2014, v. 7, n. 5, p. 253, doi. 10.1177/1756285614540361
- By:
- Publication type:
- Article
4
Extended interval dosing of natalizumab: a two-center, 7-year experience.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2014, v. 7, n. 5, p. 227, doi. 10.1177/1756285614540224
- By:
- Publication type:
- Article